Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • NeuroSciences Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Saudi Medical Journal
  • Other Publications
    • NeuroSciences Journal
  • My alerts
  • Log in
Saudi Medical Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Research ArticleOriginal Article
Open Access

Prevalence of CEA, CA 125, and CA 15-3 serum tumour markers in different regions of Saudi Arabia

Abrar Ashi, Marwan Al-Hajeili, Sarah Almaghrabi, Jaudah Al-Maghrabi, Nora Trabulsi, Shmoukh Alghuraibi, Rawaih Alsiary and Nuha Alrayes
Saudi Medical Journal June 2024, 45 (6) 565-571; DOI: https://doi.org/10.15537/smj.2024.45.6.20230878
Abrar Ashi
From the Department of Medical Laboratory Sciences (Ashi, Almaghrabi, Alrayes), Faculty of Applied Medical Sciences; from the Regenerative Medicine Unit (Ashi), King Fahd Medical Research Center; from the Center of Innovations in Personalized Medicine (Almaghrabi); from the Department of Medicine (Al-Hajeili); from the Department of Pathology (Al-Maghrabi); from the Department of Surgery (Trabulsi), Faculty of Medicine, King Abdulaziz University, from King Abdullah International Medical Research Centre (Alsiary), King Saud bin Abdulaziz University for Health Sciences, and from the Research and Development Unit (Alghuraibi), Al Borg Medical Laboratories, Al Borg Diagnostics, Jeddah, Kingdom of Saudi Arabia.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Abrar Ashi
  • For correspondence: [email protected]
Marwan Al-Hajeili
From the Department of Medical Laboratory Sciences (Ashi, Almaghrabi, Alrayes), Faculty of Applied Medical Sciences; from the Regenerative Medicine Unit (Ashi), King Fahd Medical Research Center; from the Center of Innovations in Personalized Medicine (Almaghrabi); from the Department of Medicine (Al-Hajeili); from the Department of Pathology (Al-Maghrabi); from the Department of Surgery (Trabulsi), Faculty of Medicine, King Abdulaziz University, from King Abdullah International Medical Research Centre (Alsiary), King Saud bin Abdulaziz University for Health Sciences, and from the Research and Development Unit (Alghuraibi), Al Borg Medical Laboratories, Al Borg Diagnostics, Jeddah, Kingdom of Saudi Arabia.
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Almaghrabi
From the Department of Medical Laboratory Sciences (Ashi, Almaghrabi, Alrayes), Faculty of Applied Medical Sciences; from the Regenerative Medicine Unit (Ashi), King Fahd Medical Research Center; from the Center of Innovations in Personalized Medicine (Almaghrabi); from the Department of Medicine (Al-Hajeili); from the Department of Pathology (Al-Maghrabi); from the Department of Surgery (Trabulsi), Faculty of Medicine, King Abdulaziz University, from King Abdullah International Medical Research Centre (Alsiary), King Saud bin Abdulaziz University for Health Sciences, and from the Research and Development Unit (Alghuraibi), Al Borg Medical Laboratories, Al Borg Diagnostics, Jeddah, Kingdom of Saudi Arabia.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaudah Al-Maghrabi
From the Department of Medical Laboratory Sciences (Ashi, Almaghrabi, Alrayes), Faculty of Applied Medical Sciences; from the Regenerative Medicine Unit (Ashi), King Fahd Medical Research Center; from the Center of Innovations in Personalized Medicine (Almaghrabi); from the Department of Medicine (Al-Hajeili); from the Department of Pathology (Al-Maghrabi); from the Department of Surgery (Trabulsi), Faculty of Medicine, King Abdulaziz University, from King Abdullah International Medical Research Centre (Alsiary), King Saud bin Abdulaziz University for Health Sciences, and from the Research and Development Unit (Alghuraibi), Al Borg Medical Laboratories, Al Borg Diagnostics, Jeddah, Kingdom of Saudi Arabia.
MD, FRCPC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nora Trabulsi
From the Department of Medical Laboratory Sciences (Ashi, Almaghrabi, Alrayes), Faculty of Applied Medical Sciences; from the Regenerative Medicine Unit (Ashi), King Fahd Medical Research Center; from the Center of Innovations in Personalized Medicine (Almaghrabi); from the Department of Medicine (Al-Hajeili); from the Department of Pathology (Al-Maghrabi); from the Department of Surgery (Trabulsi), Faculty of Medicine, King Abdulaziz University, from King Abdullah International Medical Research Centre (Alsiary), King Saud bin Abdulaziz University for Health Sciences, and from the Research and Development Unit (Alghuraibi), Al Borg Medical Laboratories, Al Borg Diagnostics, Jeddah, Kingdom of Saudi Arabia.
FRCSC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shmoukh Alghuraibi
From the Department of Medical Laboratory Sciences (Ashi, Almaghrabi, Alrayes), Faculty of Applied Medical Sciences; from the Regenerative Medicine Unit (Ashi), King Fahd Medical Research Center; from the Center of Innovations in Personalized Medicine (Almaghrabi); from the Department of Medicine (Al-Hajeili); from the Department of Pathology (Al-Maghrabi); from the Department of Surgery (Trabulsi), Faculty of Medicine, King Abdulaziz University, from King Abdullah International Medical Research Centre (Alsiary), King Saud bin Abdulaziz University for Health Sciences, and from the Research and Development Unit (Alghuraibi), Al Borg Medical Laboratories, Al Borg Diagnostics, Jeddah, Kingdom of Saudi Arabia.
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rawaih Alsiary
From the Department of Medical Laboratory Sciences (Ashi, Almaghrabi, Alrayes), Faculty of Applied Medical Sciences; from the Regenerative Medicine Unit (Ashi), King Fahd Medical Research Center; from the Center of Innovations in Personalized Medicine (Almaghrabi); from the Department of Medicine (Al-Hajeili); from the Department of Pathology (Al-Maghrabi); from the Department of Surgery (Trabulsi), Faculty of Medicine, King Abdulaziz University, from King Abdullah International Medical Research Centre (Alsiary), King Saud bin Abdulaziz University for Health Sciences, and from the Research and Development Unit (Alghuraibi), Al Borg Medical Laboratories, Al Borg Diagnostics, Jeddah, Kingdom of Saudi Arabia.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nuha Alrayes
From the Department of Medical Laboratory Sciences (Ashi, Almaghrabi, Alrayes), Faculty of Applied Medical Sciences; from the Regenerative Medicine Unit (Ashi), King Fahd Medical Research Center; from the Center of Innovations in Personalized Medicine (Almaghrabi); from the Department of Medicine (Al-Hajeili); from the Department of Pathology (Al-Maghrabi); from the Department of Surgery (Trabulsi), Faculty of Medicine, King Abdulaziz University, from King Abdullah International Medical Research Centre (Alsiary), King Saud bin Abdulaziz University for Health Sciences, and from the Research and Development Unit (Alghuraibi), Al Borg Medical Laboratories, Al Borg Diagnostics, Jeddah, Kingdom of Saudi Arabia.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    - Characteristics of CEA, CA 125, and CA 15-3 tumor markers (TM) in relation to age and gender. A) Line graph of mean levels of CEA, CA 125, and CA 15-3 TMs in relation to age. CEA and CA 13-5 show consistent increases in relation to age. CA 125 level peaks at ages 81-90. B) Mean of CEA TMs in relation to age and gender. C) Mean of CA 125 TMs in relation to age and gender. D) Mean of CA 15-3 TMs in relation to age and gender. Thickened lines represent the cutoff values of TMs: CEA (5 U/ml), CA 125 (35 U/ml), and CA 15-3 (31.3 U/ml).

Tables

  • Figures
    • View popup
    Table 1

    - Patient characteristics and CEA, CA 125, and CA 15-3 tumor marker levels in the study population..

    Characteristicsn (%)
    Gender
    Male92 (1.3)
    Female6,924 (98.7)
    Age (years)
    15-301,198 (17.1)
    31-401,759 (25.1)
    41-501,483 (21.1)
    51-601,138 (16.2)
    61-70848 (12.1)
    71-80433 (6.2)
    81-90129 (1.8)
    91-10028 (0.4)
    Demographic regions
    Northern Region296 (4.2)
    Central Region2,072 (29.5)
    Eastern Region524 (7.5)
    Western Region3,007 (42.9)
    Southern Region1,117 (15.9)
    Classification
    Referred by hospital465 (6.6)
    Self-referred6,551 (93.4)
    CEA levels
    Abnormal150 (2.1)
    Normal6,866 (97.9)
    CA 125 levels
    Abnormal375 (5.3)
    Normal6,641 (94.7)
    CA 15-3 levels
    Abnormal114 (1.6)
    Normal6,902 (98.4)
    • Values are presented as numbers and percentages (%).

    • CEA: carcinoembryonic antigen, CA 125: cancer antigen 125, CA 15-3: cancer antigen 15-3

    • View popup
    Table 2

    - Characterization of CEA, CA 125, and CA 15-3 tumor markers, by gender and age.

    CharacteristicsCEACA 125CA 15-3
    Gender
    Male2.36±1.7324.95±69.61*14.44±14.33
    Female2.36±29.4817.73±33.9014.17±12.78
    Age (years)
    15-301.67±0.5918.23±22.1912.63±5.29
    31-403.08±58.2018.02±17.8113.38±6.29
    41-501.77±1.1319.29±33.6614.75±23.85
    51-602.29±6.5916.29±48.5614.43±7.99
    61-702.52±2.2614.24±30.3115.41±9.88
    71-802.90±2.4617.23±45.2115.38±7.35
    81-903.28±2.50*32.00±94.54*17.53±10.72
    91-1003.10±1.3625.04±39.5418.08±9.25*
    • Values are presented as mean ± standard deviation (SD).

    • ↵* Elevated levels of serum tumor marker, according to gender and age groups.

    • CEA: carcinoembryonic antigen, CA 125: cancer antigen 125, CA 15-3: cancer antigen 15-3

    • View popup
    Table 3

    - Cross-tabulation with Chi-square test of age in CEA, CA 125, and CA 15-3 results.

    Tumor markersn (%)Chi-square
    ValuedfP-values*
    CEA
    Abnormal150 (2.11)274.0670.0001
    Normal6866 (97.6)
    CA 125
    Abnormal375 (5.21)48.0170.0001
    Normal6641 (94.8)
    CA 13-5
    Abnormal114 (1.51)65.1870.0001
    Normal6904 (98.50)
    • ↵* Significant at 0.01 level.

    • CEA: carcinoembryonic antigen, CA 125: cancer antigen 125, CA 15-3: cancer antigen 15-3

PreviousNext
Back to top

In this issue

Saudi Medical Journal: 45 (6)
Saudi Medical Journal
Vol. 45, Issue 6
1 Jun 2024
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Saudi Medical Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prevalence of CEA, CA 125, and CA 15-3 serum tumour markers in different regions of Saudi Arabia
(Your Name) has sent you a message from Saudi Medical Journal
(Your Name) thought you would like to see the Saudi Medical Journal web site.
Citation Tools
Prevalence of CEA, CA 125, and CA 15-3 serum tumour markers in different regions of Saudi Arabia
Abrar Ashi, Marwan Al-Hajeili, Sarah Almaghrabi, Jaudah Al-Maghrabi, Nora Trabulsi, Shmoukh Alghuraibi, Rawaih Alsiary, Nuha Alrayes
Saudi Medical Journal Jun 2024, 45 (6) 565-571; DOI: 10.15537/smj.2024.45.6.20230878

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prevalence of CEA, CA 125, and CA 15-3 serum tumour markers in different regions of Saudi Arabia
Abrar Ashi, Marwan Al-Hajeili, Sarah Almaghrabi, Jaudah Al-Maghrabi, Nora Trabulsi, Shmoukh Alghuraibi, Rawaih Alsiary, Nuha Alrayes
Saudi Medical Journal Jun 2024, 45 (6) 565-571; DOI: 10.15537/smj.2024.45.6.20230878
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgment
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Exploring communication challenges with children and parents among pharmacists in Saudi Arabia
  • Exploring hypothyroidism’s effects on lipid profiles
  • Assessment of asthma control levels in a tertiary hospital
Show more Original Article

Similar Articles

Keywords

  • serum tumour markers
  • CEA
  • CA 125
  • CA 15-3

CONTENT

  • home

JOURNAL

  • home

AUTHORS

  • home
Saudi Medical Journal

© 2025 Saudi Medical Journal Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.

Powered by HighWire